LENZ Therapeutics announces submission of New Drug Application to FDA for LNZ100 for treatment of presbyopia August 19, 2024 Categories: Health Care Tags: LENZ Therapeutics
LENZ Therapeutics announces completion of merger with Graphite Bio and provides update on recent clinical and corporate progress March 22, 2024 Categories: Health Care Tags: LENZ Therapeutics
LENZ Therapeutics and Graphite Bio announce merger agreement November 16, 2023 Categories: Health Care Tags: LENZ Therapeutics
